Re-entry ventricular arrhythmia
| Re-entry ventricular arrhythmia | |
|---|---|
| Synonyms | Reentrant ventricular arrhythmia |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Palpitations, dizziness, syncope, chest pain, shortness of breath |
| Complications | Sudden cardiac death, heart failure |
| Onset | Sudden |
| Duration | Variable |
| Types | N/A |
| Causes | Re-entry circuit in the ventricles |
| Risks | Coronary artery disease, cardiomyopathy, myocardial infarction, heart surgery |
| Diagnosis | Electrocardiogram (ECG), Holter monitor, electrophysiological study |
| Differential diagnosis | Atrial fibrillation, ventricular tachycardia, ventricular fibrillation |
| Prevention | Beta blockers, antiarrhythmic drugs, catheter ablation |
| Treatment | Medications, implantable cardioverter-defibrillator (ICD), radiofrequency ablation |
| Medication | N/A |
| Prognosis | Variable, depends on underlying condition and treatment |
| Frequency | Common in patients with structural heart disease |
| Deaths | N/A |
Re-entry Ventricular Arrhythmia is a type of cardiac arrhythmia that occurs when a disturbance in the heart's electrical conduction system leads to rapid, uncoordinated heartbeats originating in the ventricles, the lower chambers of the heart. This condition is a significant concern because it can compromise cardiac output and lead to serious complications, including sudden cardiac death.
Causes[edit]
Re-entry ventricular arrhythmia is primarily caused by the presence of a "re-entry circuit" within the heart's ventricular tissue. This situation can arise due to various factors, including:
- Myocardial infarction (heart attack), which can create scar tissue that disrupts the normal flow of electrical impulses.
- Cardiomyopathy, a disease of the heart muscle that affects its size, shape, and structure.
- Electrolyte imbalances, particularly involving potassium and magnesium, which are critical for the proper electrical functioning of the heart.
- Genetic conditions, such as Long QT Syndrome and Brugada Syndrome, which affect the heart's electrical properties.
Symptoms[edit]
Symptoms of re-entry ventricular arrhythmia can vary widely among individuals, ranging from no symptoms at all to severe manifestations, including:
- Palpitations, a sensation of the heart racing or pounding
- Dizziness or lightheadedness
- Syncope (fainting)
- Chest pain
- In severe cases, cardiac arrest
Diagnosis[edit]
Diagnosis of re-entry ventricular arrhythmia involves a combination of clinical evaluation and diagnostic tests, including:
- Electrocardiogram (ECG or EKG), which records the electrical activity of the heart and can identify abnormal rhythms.
- Holter monitor, a portable ECG device worn for 24 hours or longer to record the heart's activity over time.
- Electrophysiological study (EPS), an invasive test where catheters are inserted into the heart to study its electrical system and identify re-entry circuits.
Treatment[edit]
Treatment for re-entry ventricular arrhythmia aims to prevent future episodes and reduce the risk of complications. Options include:
- Antiarrhythmic drugs, which help regulate the heart's rhythm.
- Catheter ablation, a procedure that destroys the tissue forming the re-entry circuit, thereby interrupting the abnormal electrical pathway.
- Implantable cardioverter-defibrillator (ICD), a device implanted in the chest to monitor the heart's rhythm and deliver electrical shocks when a dangerous arrhythmia is detected.
- Lifestyle modifications, including dietary changes, exercise, and avoiding triggers like alcohol and caffeine, may also be recommended.
Prognosis[edit]
The prognosis for individuals with re-entry ventricular arrhythmia varies depending on the underlying cause, the presence of heart disease, and the effectiveness of treatment. With appropriate management, many patients can lead normal, active lives.